Introduction: An estimated 1.2 million Americans have indications for using antiretroviral pre-exposure prophylaxis (PrEP) to prevent HIV acquisition. For many of these at-risk individuals, the best opportunity to learn about and receive PrEP will be during routine visits to their generalist primary care clinicians. However, few generalist clinicians have prescribed PrEP, primarily because of practical concerns about providing PrEP in primary care settings. The experiences of specialized primary care clinicians who have prescribed PrEP can inform the feasibility of PrEP provision by generalists. Methods: During January to February 2015, 35 primary care clinicians at a community health centre in Boston that specializes in the care of sexual ...
abstract: Background: In 2012 the U.S. Food and Drug Administration (FDA) approved the drug emtricit...
A global human immunodeficiency virus (HIV) epidemic persists despite data to support multiple effec...
A recent clinical trial demonstrated that a daily dose tenofovir disoproxil fumarate and emtricitabr...
Background: Around 1.2 million people in the United States (U.S.) are currently infected with Human ...
OBJECTIVES:As trials were assessing the safety and efficacy of daily oral antiretroviral preexposure...
Purpose. This quality improvement project focused on educating primary care providers (PCPs) about p...
Optimizing access to HIV pre-exposure prophylaxis (PrEP), an evidence-based HIV prevention resource,...
The Southern United States (U.S.) accounts for more than half of new HIV cases annually and African ...
Background and objectivesLess than 10 percent of the more than one million people vulnerable to HIV ...
infections per year in the United States, we need more effective HIV prevention strategies. The use ...
The purpose of this project was to improve primary care provider knowledge, attitude and behaviors r...
Abstract Objective: The purpose of this study was to examine the experiences of men who seek pre-...
INTRODUCTION:Pharmacist provision of pre-exposure prophylaxis (PrEP) through collaborative practice ...
Human immunodeficiency virus (HIV) is an incurable condition that continues to be a public health th...
HIV infections have been, and continue to be, a significant health concern for the United States. Th...
abstract: Background: In 2012 the U.S. Food and Drug Administration (FDA) approved the drug emtricit...
A global human immunodeficiency virus (HIV) epidemic persists despite data to support multiple effec...
A recent clinical trial demonstrated that a daily dose tenofovir disoproxil fumarate and emtricitabr...
Background: Around 1.2 million people in the United States (U.S.) are currently infected with Human ...
OBJECTIVES:As trials were assessing the safety and efficacy of daily oral antiretroviral preexposure...
Purpose. This quality improvement project focused on educating primary care providers (PCPs) about p...
Optimizing access to HIV pre-exposure prophylaxis (PrEP), an evidence-based HIV prevention resource,...
The Southern United States (U.S.) accounts for more than half of new HIV cases annually and African ...
Background and objectivesLess than 10 percent of the more than one million people vulnerable to HIV ...
infections per year in the United States, we need more effective HIV prevention strategies. The use ...
The purpose of this project was to improve primary care provider knowledge, attitude and behaviors r...
Abstract Objective: The purpose of this study was to examine the experiences of men who seek pre-...
INTRODUCTION:Pharmacist provision of pre-exposure prophylaxis (PrEP) through collaborative practice ...
Human immunodeficiency virus (HIV) is an incurable condition that continues to be a public health th...
HIV infections have been, and continue to be, a significant health concern for the United States. Th...
abstract: Background: In 2012 the U.S. Food and Drug Administration (FDA) approved the drug emtricit...
A global human immunodeficiency virus (HIV) epidemic persists despite data to support multiple effec...
A recent clinical trial demonstrated that a daily dose tenofovir disoproxil fumarate and emtricitabr...